These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19721463)

  • 1. The case for open-access chemical biology. A strategy for pre-competitive medicinal chemistry to promote drug discovery.
    Weigelt J
    EMBO Rep; 2009 Sep; 10(9):941-5. PubMed ID: 19721463
    [No Abstract]   [Full Text] [Related]  

  • 2. Medicinal chemistry at a crossroads: challenges and new possibilities.
    Ojima I
    Future Med Chem; 2009 Jun; 1(3):401-3. PubMed ID: 21426118
    [No Abstract]   [Full Text] [Related]  

  • 3. Ask the experts: the challenges and benefits of flow chemistry to optimize drug development.
    Anderson N; Gernaey KV; Jamison TF; Kircher M; Wiles C; Leadbeater NE; Sandford G; Richardson P
    Future Med Chem; 2012 Sep; 4(14):1779-89. PubMed ID: 23043475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating effective medicinal chemistry collaborations in drug discovery.
    Giardina GA; Raveglia LF
    Future Med Chem; 2009 Apr; 1(1):3-6. PubMed ID: 21426065
    [No Abstract]   [Full Text] [Related]  

  • 5. New drug development.
    Hoffman SJ; Pogge T; Hollis A
    Lancet; 2011 Mar; 377(9769):901-2. PubMed ID: 21397761
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology.
    Hoffmann T; Bishop C
    Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fragment-based drug discovery: what really works. An interview with Sandy Farmer of Boehringer Ingelheim.
    Farmer S
    J Comput Aided Mol Des; 2011 Jul; 25(7):599-605. PubMed ID: 21766241
    [No Abstract]   [Full Text] [Related]  

  • 8. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry.
    Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A
    Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients not patents: Drug research and development as a public enterprise.
    Gøtzsche PC
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29243246
    [No Abstract]   [Full Text] [Related]  

  • 10. Interview with Future Medicinal Chemistry's US Senior Editor, Iwao Ojima. Interview by Issac Bruce.
    Ojima I
    Future Med Chem; 2012 Oct; 4(16):2019-22. PubMed ID: 23157234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 12. Incentives aim to boost antibiotic development.
    Roberts JP
    Nat Biotechnol; 2012 Aug; 30(8):735. PubMed ID: 22871701
    [No Abstract]   [Full Text] [Related]  

  • 13. Open Access Could Transform Drug Discovery: A Case Study of JQ1.
    Arshad Z; Smith J; Roberts M; Lee WH; Davies B; Bure K; Hollander GA; Dopson S; Bountra C; Brindley D
    Expert Opin Drug Discov; 2016; 11(3):321-32. PubMed ID: 26791045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State Initiatives to Control Medication Costs--Can Transparency Legislation Help?
    Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2016 Jun; 374(24):2301-4. PubMed ID: 27305189
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-diagnostic co-development: how to harness the value.
    Blair ED; Blakemore JA
    Drug Discov Today; 2011 Oct; 16(19-20):902-5. PubMed ID: 21888987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction: pharmaceutical innovation: law & the public's health.
    Outterson K
    J Law Med Ethics; 2009; 37(2):173-5. PubMed ID: 19493064
    [No Abstract]   [Full Text] [Related]  

  • 17. Oncology pharmaceutical funding in New Zealand: a different approach and a proposal.
    Beatty PA; Laking GR
    J Oncol Pract; 2015 May; 11(3):249-51. PubMed ID: 25829524
    [No Abstract]   [Full Text] [Related]  

  • 18. Health, trade, and industry officials set to debate access to essential drugs.
    Kapp C
    Lancet; 2001 Apr; 357(9262):1105. PubMed ID: 11297977
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines for tropical diseases; support through tax-incentives.
    John JE
    Drug Discov Today; 2011 Feb; 16(3-4):91-2. PubMed ID: 21111059
    [No Abstract]   [Full Text] [Related]  

  • 20. Open access chemical and clinical probes to support drug discovery.
    Edwards AM; Bountra C; Kerr DJ; Willson TM
    Nat Chem Biol; 2009 Jul; 5(7):436-40. PubMed ID: 19536100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.